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Protein arginine methyltransferase 1 (PRMT1) is involved in
cell proliferation, DNA damage response, and transcriptional
regulation. Although PRMT1 is extensively expressed in the
CNS at embryonic and perinatal stages, the physiological role of
PRMT1 has been poorly understood. Here, to investigate the
primary function of PRMT1 in the CNS, we generated CNS-
specific PRMT1 knock-out mice by the Cre-loxP system. These
mice exhibited postnatal growth retardation with tremors, and
most of them died within 2 weeks after birth. Brain histological
analyses revealed prominent cell reduction in the white matter
tracts of themutantmice. Furthermore, ultrastructural analysis
demonstrated thatmyelin sheathwas almost completely ablated
in the CNS of these animals. In agreement with hypomyelina-
tion, we also observed that most major myelin proteins includ-
ingmyelin basic protein (MBP), 2,3-cyclic-nucleotide 3-phos-
phodiesterase (CNPase), and myelin-associated glycoprotein
(MAG) were dramatically decreased, although neuronal and
astrocytic markers were preserved in the brain of CNS-specific
PRMT1 knock-out mice. These animals had a reduced number
of OLIG2 oligodendrocyte lineage cells in the white matter.
We found that expressions of transcription factors essential for
oligodendrocyte specification and further maturation were sig-
nificantly suppressed in the brain of the mutant mice. Our find-
ings provide evidence that PRMT1 is required for CNS develop-
ment, especially for oligodendrocyte maturation processes.
CNS development is achieved by proliferation of progenitor
cells followed by the transition from a proliferative state to dif-
ferentiation. This process is considered to be tightly regulated
at multiple levels such as gene transcription, translation, and
proteinmodification. In the oligodendrocyte lineage, transcrip-
tion factors are known to determine cell fate and timing of
differentiation by inducing the target genes that are critical for
myelination (1–3). Moreover, emerging evidence suggests that
post-translational modification of proteins is one of the impor-
tant determinants for oligodendrocyte lineage progression (4).
For example, phosphorylation of retinoblastoma protein by
AMP-activated protein kinase is essential for cell cycle progres-
sion in neural stem cells (NSCs)2 and their differentiation into
cell types including neurons and oligodendrocytes (5). On the
other hand, a histone lysine deacetylase, SIRT1, has a role in
limiting the expansion of oligodendrocyte precursor cells
(OPCs) (6). However, there is no in vivo evidence for the
involvement ofmethylation enzymes in oligodendrocyte devel-
opment and myelination.
Protein arginine methylation is now widely accepted as one
of the major post-translational modifications observed in both
histone and non-histone proteins. Protein arginine methyl-
transferase (PRMT) 1, one of the type I PRMTs that catalyze
monomethylation and asymmetric dimethylation of proteins,
regulates transcription, cell death, DNAdamage responses, and
signal transduction as reviewed elsewhere (7). In mammals,
PRMT1 is ubiquitously expressed in various tissues (8–11).
Previous studies demonstrated thatmouse embryos that lack
PRMT1 were arrested in development before embryonic day
6.5, suggesting that arginine methylation by PRMT1 is crucial
for early embryonic development (9). Interestingly, the distri-
bution pattern of PRMT1 in mouse embryo has shown high
expression in neural tube during embryonic stage (9). After
birth, PRMT1 is still strongly expressed in the brain during the
perinatal stage (12). It should be noted that PRMT5, the most
characterized member of type II PRMTs that catalyze the
monomethylation and symmetric dimethylation of proteins,
also shows substantial expression in the brain (12). Specific
deletion of PRMT5 in CNS results in postnatal lethality with
extensive apoptosis of NSCs (13). In addition, Chittka et al. (14)
have demonstrated that PRMT5 controls NSC proliferation
and differentiation. These studies indicate the important role of
PRMTs in the CNS; however, little is known about PRMT1 in
the development of nervous tissues.
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Here, our results demonstrate the essential function of
PRMT1 for proper organization of the CNS by using PRMT1
conditional knock-out mice and highlights the crucial role in
oligodendrocyte lineage.
Experimental Procedures
Animals—PRMT1 knock-in mice (PRMT1-KI) that carry
Prmt1tm1a(EUCOMM)Wtsi allele were obtained from the Euro-
pean ConditionalMouseMutagenesis (EUCOMM). For gener-
ation of Prmt1flox/floxmice, the gene trap cassette was removed
by intercrossing -actin-Flp transgenic mouse (strain name:
B6.SJL-Tg(ACTFLPe)9205Dym/J, stock number: 003800, The
Jackson Laboratory). Prmt1flox/flox mice were further crossed
with Nestin-Cre transgenic mice (B6.Cg-Tg(Nes-cre)1Kln/J,
stock number: 003771, The Jackson Laboratory) to create
Prmt1flox/flox; Nes-Cremice.
Genotyping of mice was performed by PCR using genomic
DNA from tail as described previously (15). The primers were
Prmt1 forward primer (5-GTGCTTGCCATACAAGAGA-
TCC-3) and reverse primer (5-ACAGCCGAGTAGCAAGG-
AGG-3). The primer set amplifies 410- and 277-bp fragments
for the floxed and wild-type alleles, respectively. Nestin-Cre
transgene was amplified using forward primer (5-ACTGAAC-
GCTAAAGGGTTAAG-3) and reverse primer (5-GTGAAA-
CAGCATTGCTGTCACTT-3).
All animal experiments were done in compliance with and
approved by the Institutional Animal Experiment Committee
of the University of Tsukuba. All these experiments were con-
ducted in accordance with the Regulations for Animal Experi-
ments at our institution and with the Fundamental Guidelines
for the Proper Conduct of Animal Experiments and Related
Activities in Academic Research Institutions under the juris-
diction of the Ministry of Education, Culture, Sports, Science
and Technology of Japan.
RNA Analysis—Whole brains were harvested at postnatal
day 0 (P0) or P10 and frozen in liquid nitrogen and then stored
in a deep freezer until use. Frozen tissues were crushed into
powder with a Multi-beads Shocker (Yasui Kikai Co., Osaka,
Japan). From a subset of the tissue powder, brain total RNAwas
isolated with ISOGEN II (Nippon Gene, Ltd., Tokyo, Japan)
following the manufacturer’s instructions. 5 g of the total
RNAwere treated with RQ1 RNase-Free DNase (Promega) and
then reverse-transcribed into cDNA with ReverTra Ace
(Toyobo Co., Ltd., Osaka, Japan). Relative gene expression level
was determined by SYBR Green-based quantitative RT-PCR
(Takara Bio Inc., Shiga, Japan). Expression levels of target gene
were corrected for Gapdh expression levels by using Ct
method. The amplification efficiency of primers for each target
gene was confirmed to be equal by using serial dilutions of
cDNA. The primer sequences were as follows: Olig1 (5-CTC-
GCCCAGGTGTTTTGTTG-3 and 5-TAAGTCCGAACAC-
CGATGGC-3), Olig2 (5-GAACCCCGAAAGGTGTG-
GAT-3 and 5-TTCCGAATGTGAATTAGATTTGAGG-3),
Nkx2.2 (5-CCTTTCTACGACAGCAGCGA-3 and 5-CCG-
TGCAGGGAGTATTGGAG-3), Sox10 (5-GCAGAAAGCT-
AGCCGACCA-3 and 5-CTTTCGTTCAGCAACCTCC-
AGA-3), andGapdh (5-TCACTGGCATGGCCTTCC-3 and
5-CAGGCGGCACGTCAGATC-3).
Protein Analysis—Brain and kidney tissue powder was pre-
pared as described above and was homogenized in ice-cold
radioimmunoprecipitation assay buffer containing 20mMTris-
HCl, 150mMNaCl, 1mMEDTA, 1%Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, and a proteinase
inhibitor mixture (Nacalai Tesque, Inc., Kyoto, Japan). Protein
extracts were centrifuged at 14,000 rpm for 15 min at 4 °C, and
then concentration was determined by Bio-Rad protein assay
dye reagent concentrate (Bio-Rad). Quantified total protein
extracts were denatured with Laemmli sample buffer supple-
mented with 100 mM DTT, and then subjected to 10 or 12%
SDS-PAGEand analyzed byWestern blotwith various antibod-
ies, according to standard procedures. The antibodies are as
follows: anti-PRMT1 (1:1000, rabbit polyclonal; catalog num-
ber 07-404, Millipore), anti-MBP (1:100, goat polyclonal; cata-
log number sc-13914, Santa Cruz Biotechnology), anti-CNPase
(1:1000, rabbit monoclonal; catalog number 5664, Cell Signal-
ing Technology), anti-MAG (1:1000, rabbit monoclonal; cata-
log number 9043, Cell Signaling Technology), anti-CRMP2
(1:1000, rabbit polyclonal; catalog number 9393, Cell Signaling
Technology), anti-III-tubulin (1:1000, rabbitmonoclonal; cat-
alog number 5568, Cell Signaling Technology), anti-glial fibril-
lary acidic protein (GFAP) (1:1000, mouse monoclonal; catalog
number G3893, Sigma), anti-asymmetric dimethyl arginine,
Asym26 (1:1000, rabbit polyclonal; catalog number 13-0011,
EpiCypher), anti-mono-methyl arginine (R*GG) (D5A12)
(1:1000, rabbit monoclonal; catalog number 8711, Cell Signal-
ing Technology), anti-symmetric dimethyl arginine (SDMA)
motif (1:1000, rabbit monoclonal mix; catalog number 13222,
Cell Signaling Technology), anti-GAPDH (1:10000, mouse
monoclonal; catalog number 05-50118, American Research
Products), and anti--actin (1:10000, mouse monoclonal; cata-
log number A5316, Sigma). Secondary antibodies are corre-
sponding HRP-conjugated secondary antibodies. Visualization
via chemiluminescent detection was performed using Super-
Signal West Femto maximum sensitivity substrate (Thermo
Fisher Scientific). Data images were obtained from an LAS-
3000 (Fujifilm, Tokyo, Japan).
Histology—Mice were transcardially perfused with 4% para-
formaldehyde, immersed in the same fixative for 24 h at 4 °C,
and embedded in paraffin. Tissues were sectioned into 7-m
thickness using a rotary microtome (HM340E; Microm Inter-
national GmbH, Walldorf, Germany). Brains were sectioned
either in the midline sagittal plane or in the coronal section at
the level of the mid-cerebellum and the forebrain. Spinal cord
tissues were sectioned at the thoracic level with the surround-
ing bones. Deparaffinized sections were stained with H&E.
Data images were obtained using a SZ61 microscope, a BX53
microscope, and a DP21 digital camera (Olympus, Tokyo,
Japan). Three to five mice per each genotype were used for
histological studies.
Immunohistochemistry—For immunohistochemistry, tissue
sections were deparaffinized, followed by antigen retrieval with
citrate buffer (pH 6.0), and then incubated in 3% H2O2 for 30
min to quench an endogenous peroxidase. Sections were incu-
bated with TSA blocking reagent (catalog number FP1020,
PerkinElmer) for 30min andwith each primary antibody for 1 h
at room temperature. The antibodies usedwere as follows: anti-
Loss of PRMT1 in CNS Leads to Hypomyelination
2238 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 5•JANUARY 29, 2016
 at TSU
K
U
BA
 D
A
IG
A
K
U
 on January 20, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
MBP (1:1000, goat polyclonal; catalog number sc-13914, Santa
Cruz Biotechnology) and anti-OLIG2 (1:1000–1:2000, rabbit
polyclonal; catalog number 18953, Immuno-Biological Lab-
oratories, Gunma, Japan). Biotinylated horse anti-goat IgG
(catalog number BA-9500, Vector Laboratories) or biotiny-
lated goat anti-rabbit IgG (catalog number BA-1000, Vector
Laboratories) was incubated for 30 min, and then reacted
with streptavidin-HRP (catalog number NEL750001EA,
PerkinElmer) for 30 min. Signal was amplified with the TSA
Plus fluorescein system or TSA Plus tetramethylrhodamine
(TMR) system (catalog number NEL756001KT Perkin-
Elmer) for 10min, followed by Hoechst counterstaining. Flu-
orescence images were obtained with a fluorescence micro-
scope (BIOREVO BZ-9000, Keyence, Osaka, Japan) and
FluoView FV10i confocal laser-scanning microscope (Olym-
pus, Tokyo, Japan). For the quantification of immunohisto-
chemical data, three mice per each genotype were evaluated
with the ImageJ software.
Transmission Electron Microscopy—For ultrastructure anal-
ysis, mice were perfused with 2% glutaraldehyde/2% parafor-
maldehyde, and then brain and spinal cord were dissected, fol-
lowed by immersion fixation in 2.5% glutaraldehyde in 0.1 M
phosphate buffer. Tissues were then processed as standard pro-
cedure, and ultrathin sections were subjected to transmission
electron microscopy analysis with a JEM-1400 electron micro-
scope (JEOL USA) at the electron microscopy facility at the
University of Tsukuba. For transmission electron microscope
analysis, multiple numbers of sections from 2–3 mice per each
genotype were analyzed.
LC-MS/MS Analysis—Brain tissue powder was prepared as
described above and was homogenized in ice-cold deionized
water. Protein extracts were centrifuged at 14,000 rpm for 10
min at 4 °C, and then concentration was determined by the
Bio-Rad DC protein assay (Bio-Rad). Quantified total protein
extracts were further precipitated with 10% TCA in cold ace-
tone. The total proteins were hydrolyzed with 6 NHCl at 110 °C
for 24 h. After hydrolysis, the residues were evaporated in
vacuo, and then reconstituted in 100 l of deionized water for
the following LC-MS/MS analysis.
The LC-MS/MS analysis was performed on a Shimadzu
LCMS-8050 triple quadrupolemass spectrometer coupledwith
a Shimadzu Nexera X2 ultra-high pressure liquid chromatog-
raphy (UHPLC) system (Shimadzu, Kyoto, Japan). The instru-
ment was operated under positive electrospray ionization and
multiple reaction monitoring modes. The chromatography
separation was performed with a SeQuant ZIC-HILIC column,
2.1  150 mm, 3.5 m (Millipore) with gradient elution com-
prising distilled water containing 1% formic acid and 1% aceto-
nitrile (mobile phase A) and acetonitrile containing 1% formic
acid and 1%water (mobile phase B). A ZIC-HILIC guard-fitting
column, 1.0  14 mm (Millipore), was installed before the
SeQuant ZIC-HILIC column for the sake of sample cleanup.
The MS operating conditions were optimized as follows: inter-
face voltage, 4.0 kV; interface temperature, 300 °C; desolvation
line temperature, 250 °C; heating block temperature, 400 °C;
drying gas (N2); 10 liters min1; nebulizing gas (N2); 3 liters
min1; heating gas (air), 10 liters min1; and collision-induced
dissociation gas (argon), 230 kilopascals. For the detection of
asymmetric dimethyl arginine (ADMA), monomethyl arginine
(MMA), and SDMA, the gradient program for positive ioniza-
tion method started from 95% mobile phase B at 0–1 min, was
decreased at 5–10 min, and then was stopped at 14 min. The
mobile phase B content was further increased to 95% at 14.10
min and stopped at 21 min with a flow rate of 0.2 ml/min. The
m/z values for each analyte are as follow: ADMA, 203.15 
158.05; MMA, 189.15  70.15; SDMA, 203.25  171.95. All
analyses and data processing were completed with the Lab-
Solutions V5.60 software (Shimadzu Scientific Instruments,
Inc., Columbia, MD). Four mice per each genotype were used
for LC-MS/MS analysis.
Results
PRMT1 Deletion in the CNS Causes Postnatal Lethality of
Mice—To address the primary function of PRMT1 in the CNS,
we producedCNS-specific PRMT1 knock-outmice.Prmt1KI/KI
mice were mated with -actin-Flp transgenic mice to produce
Prmt1flox/flox mice. In Prmt1flox allele, exons 4 and 5, which
encode a part of the methyltransferase domains, are flanked by
two loxP sites, enabling us to obtain functional null allele by
Cre-mediated recombination. Prmt1flox/flox mice were crossed
to animals expressing Nestin-Cre (Nes-Cre) to generate
Prmt1flox/flox; Nes-Cre animals (referred to as CKO in the fig-
ures) (Fig. 1, A and B) (16). In the whole brain lysates from
embryos and postnatal mice, we confirmed the marked reduc-
tion of PRMT1 protein level by Western blot, whereas other
tissues such as kidney expressed PRMT1normally (Fig. 1,C and
D). In the brain, there were faint remnants of expression that
were possibly from Nestin-Cre inactive components such as
vessels or from incomplete recombination at the Prmt1 gene
locus.
Prmt1flox/flox; Nes-Cre animals were born close to the
normal Mendelian ratio (Table 1) and appeared to be normal
at birth. Their body weights were similar when
compared with other littermates including Prmt1flox/flox,
Prmt1flox/wt; Nes-Cre, and Prmt1flox/wt on the day of birth (Fig.
1E). However, Prmt1flox/flox; Nes-Cre animals displayed postna-
tal lethality, and all mice in this group died within 17 days after
birth (Fig. 1F).
Loss of PRMT1 in the CNS Results in Dynamic Changes in
Methyl Arginine Levels in the Brain—Because PRMT1 catalyzes
the formation of ADMA in proteins, we performed acid hydro-
lysis of proteins from the whole brain tissue and measured the
level of ADMA by LC-MS/MS. As shown in Fig. 2A, ADMA
levels in Prmt1flox/flox; Nes-Cre mice were almost 2-fold lower
than those of Prmt1flox/floxmice. The decrease of tissue ADMA
levels was also confirmed by Western blot using an antibody
against ADMA (Fig. 2B). Altogether, these results indicate that
PRMT1 serves as a major methyltransferase that catalyzes the
formation of ADMA in the mouse brain.
Deletion of PRMT1 in mouse embryonic fibroblasts induces
up-regulation of MMA and SDMA levels (17). We therefore
examined the level of MMA and SDMA in brain tissues by
LC-MS/MS and Western blot. Both MMA and SDMA levels
showed dramatic elevation in Prmt1flox/flox; Nes-Cre pups when
compared with Prmt1flox/flox mice (Fig. 2, A and B), suggesting
Loss of PRMT1 in CNS Leads to Hypomyelination
JANUARY 29, 2016•VOLUME 291•NUMBER 5 JOURNAL OF BIOLOGICAL CHEMISTRY 2239
 at TSU
K
U
BA
 D
A
IG
A
K
U
 on January 20, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
that the loss of PRMT1 actually affected the status of protein
arginine methylation on multiple proteins in agreement with
the previous in vitro work (17).
Growth Retardation and Reduced Nuclei in theWhiteMatter
in Prmt1flox/flox; Nes-Cre Mice—We then characterized the
brain morphology and the behavioral outcomes to clarify the
effect of PRMT1 deletion in the CNS. Prmt1flox/flox; Nes-Cre
animals started to show growth retardation at about P4 (Fig.
3A); their body size was remarkably small at P10 with reduced
brain size and weight, and they were noticeably emaciated (Fig.
3, B and C). Histological analysis of nervous tissues revealed
that all white matter tracts in the CNS including corpus callo-
sum, fimbria, anterior commissure, and spinalwhitematter had
a reduced number of nuclei as indicated by hematoxylin stain-
ing. Although nuclei in both white and gray matter areas were
decreased in the spinal cords, a more prominent difference was
observed in the white matter (Fig. 4). Considering that white
matter tracts consist of predominantly oligodendrocytes and a
much lower number of nuclei of neuron and astrocytes, our
data imply that cellular organizations are changed in the CNS
tissues of Prmt1flox/flox; Nes-Cremice.
FIGURE1.PRMT1deletion in theCNScausespostnatal lethalityofmice.A,
schematic view of Prmt1 gene targeting design used in this study. Black rec-
tangles represent exons, and gray arrows indicate mating with other trans-
genic mice for gene recombination. B, genotyping PCR for Prmt1 allele and
Nestin-Cre (Nes-Cre) allele. C, Western blot showing developmental time
course of PRMT1 protein expression in the brain of Prmt1flox/flox (hereafter,
CTRL) and Prmt1flox/flox; Nes-Cre (hereafter, CKO) mice. D, Western blot show-
ing PRMT1 protein expression in the kidney of CTRL and CKO mice at P10. E,
body weights of Prmt1flox/wt (n 6), Prmt1flox/wt; Nes-Cre (n 5), Prmt1flox/flox
(n 13), and Prmt1flox/flox; Nes-Cremice (n 10) at P0. The points in the graph
show individual data sets from each animal with lines and error bars indicat-
ing mean  S.E. F, Kaplan-Meier survival analysis of Prmt1flox/flox (n  106),
Prmt1flox/wt; Nes-Cre (n  88), Prmt1flox/wt (n  57), and Prmt1flox/flox; Nes-Cre
mice (n 47).
TABLE 1
Genotypesofoffspringobtained fromthe crossofPrmt1flox/wt; Nes-Cre
mice and Prmt1flox/floxmice
The numbers and percentages (in parentheses) of mice of various genotypes
obtained by crosses of Prmt1flox/wt; Nes-Cre and Prmt1flox/flox at P0 are shown. The
expected numbers and percentages of mice were calculated according to the total
number of mice born and based on the expected Mendelian 1:1:1:1 ratio.
Prmt1 Cre
Expected
no. (%)
Observed
no. (%)
fl/w  86 (25) 71 (21)
fl/w 	 86 (25) 90 (26)
fl/fl  86 (25) 109 (32)
fl/fl 	 86 (25) 73 (21)
Total 343 (100)
FIGURE 2. Loss of PRMT1 in the CNS results in dynamic change in
methyl arginine levels in the brain. A, ADMA, SDMA, and MMA levels in
the brain of CTRL and CKO mice were quantitated by LC-MS/MS at P10.
Data were obtained from acid hydrolysate of proteins from each brain
sample. The data shown are mean  S.E. and were analyzed by a two-
tailed Student’s t test. n 4 per each genotype.*, p
 0.05, **, p
 0.01. B,
ADMA, SDMA, andMMA levels in the whole brains were detected byWest-
ern blot (upper panels) at P10, and loaded protein samples on membrane
were confirmed to be equal by Coomassie Brilliant Blue (CBB) stain (lower
panels). Molecular weight (MW) markers are indicated in kDa on the right
of each panel.
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Behavioral Deficits in Prmt1flox/flox; Nes-Cre Mice—Remark-
ably, Prmt1flox/flox; Nes-Cre mice manifested ataxic behavior
and tremors, which became evident after 1 week of birth (sup-
plemental Video S1). This behavioral defect is reminiscent of
mouse models with hypomyelination such as myelin-deficient
shiverer mice (shi) (18) or quaking viable mice (qkv) (19, 20).
The similar behavioral phenotype in Prmt1flox/flox; Nes-Cre ani-
mals prompted us to analyze the level of myelination in the
CNS.
Severe Hypomyelination and Dramatic Decrease of Mature
Oligodendrocytes in Prmt1flox/flox; Nes-Cre Mice—Myelin is a
multilamellar structure that is formed by mature oligodendro-
cytes and is wrapping around a number of axons, allowing rapid
saltatory conduction in the CNS. We evaluated myelin forma-
tion at P10 because myelination actively occurs from the first
week to the third week after birth in rodents (21), and we had
difficulties in obtaining tissues after the second week due to the
short life span of Prmt1flox/flox; Nes-Cre mice. To examine the
ultrastructure of myelin sheaths, we performed transmission
electron microscope analysis and confirmed that a substantial
number of axons were myelinated in Prmt1flox/flox mice spinal
cord and brain. By contrast, in the spinal cord, only a few axons
were myelinated in Prmt1flox/flox; Nes-Cre mice. Similarly,
myelin structure was totally ablated in the corpus callosum of
Prmt1flox/flox; Nes-Cre mice (Fig. 5A). Thus, transmission elec-
tron microscope analysis clearly showed hypomyelination in
the CNS tissues of Prmt1flox/flox; Nes-Cremice.
Mature oligodendrocytes produce myelin-specific proteins
such as myelin basic protein (MBP), 2,3-cyclic-nucleotide
3-phosphodiesterase (CNPase), and myelin-associated glyco-
protein (MAG) (22, 23), allowing compact myelin formation
and axon stability. The myelin protein levels were dramatically
decreased in the Prmt1flox/flox; Nes-Cre mice when compared
with Prmt1flox/flox mice as confirmed by Western blot. On the
other hand, neuronal and astrocytic markers were observed in
the same level between Prmt1flox/flox and Prmt1flox/flox; Nes-Cre
brain (Fig. 5B). Consistent with those findings, immunohisto-
chemical analysis revealed the near complete loss of MBP-pos-
itive signals in whole brain regions including the white matter
tracts in the corpus callosum, striatum, cerebellum, and spinal
cord in Prmt1flox/flox; Nes-Cre mice (Fig. 5C), although there
were still intense signals in the spinal roots that are composed of
peripheral nerves (Fig. 5C, inset). Collectively, these data dem-
onstrated extensive dysmyelination caused by the dramatic
reduction of mature oligodendrocytes in the CNS tissues of
Prmt1flox/flox; Nes-Cremice.
Oligodendrocyte Lineage CellsWere Reduced in Prmt1flox/flox;
Nes-Cre Mice—Myelinating mature oligodendrocytes are
developmentally derived from highly proliferative OPCs that
were originally from NSCs. OPCs develop into premyelinating
oligodendrocytes and then terminally differentiate into mature
myelinating oligodendrocytes (1). Because we observed the
near complete loss ofmature oligodendrocytes, we investigated
whether OPCs and premyelinating oligodendrocytes are also
absent by immunohistochemistry for OLIG2, which indicates
all oligodendrocyte lineage cells, and MBP, which indicates
only mature oligodendrocytes. To exclude mature oligoden-
drocytes from all OLIG2	 cells, we counted the number of
OLIG2	MBP cells in the striatum and assumed them to be
OPCs or immature oligodendrocytes. We detected a reduced
number of OLIG2	 cells not only in the striatum but also in the
cerebellum and spinal cord in Prmt1flox/flox; Nes-Cremice, sug-
gesting that oligodendrocyte lineage progression is not com-
pletely but only partially suppressed (Fig. 6, A and B, upper
panels). Furthermore, Prmt1flox/flox; Nes-Cremice had less than
FIGURE3.Growth retardation inPrmt1flox/flox;Nes-Cremice.A, photograph
of representative CKOmice and other littermate controls at P4. The left three
pups (arrows) are confirmed to be Prmt1flox/flox; Nes-Cre by PCR analysis and
smaller than other littermates. Other control littermates include Prmt1flox/flox
and Prmt1flox/wt; Nes-Cre mice. Scale bar represents 1 cm. B, representative
exampleof body sizes of CTRL andCKOmice at P10. Scale bar represents 1 cm.
C, the upper panel shows the representative brain size, and the lower graph
shows the fresh brain weights from littermate controls at P10. Scale bar rep-
resents 5 mm. The points in the graph show individual data sets from each
animal with lines and error bars indicating mean  S.E. n  4–12 per each
genotype.
FIGURE 4. Histological abnormalities of the white matter parts in
Prmt1flox/flox;Nes-Cremice.Hematoxylin andeosin staining imagesofbrains
and spinal cords from CTRL and CKOmice at P10 obtained from coronal sec-
tions of tissues are shown. CC, corpus callosum; Fim, fimbria; AC, anterior
commissure; SC, spinal cord. Dotted lines represent the boundary of white
matter (WM) and gray matter (GM). Scale bars represent 100 m.
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half the number of OLIG2	MBP cells relative to Prmt1flox/flox
mice in the striatum (Fig. 6A, lower panels and graph). There-
fore, these results show that OPCs and/or premyelinating oli-
godendrocytes are dramatically reduced in PRMT1 mutant
mice.
Oligodendrocyte development ismainly promoted by several
key transcription factors, and many of these proteins belong to
the basic-helix-loop-helix (bHLH) protein family, homeodo-
main proteins, and high mobility group (HMG) domain pro-
teins. In particular, Olig1, Olig2, Nkx2.2, and Sox10 are well
characterized as positive regulators of oligodendrocyte differ-
entiation (23–27). AlthoughOlig2 is necessary for specification
of oligodendrocyte lineages, Olig1, Nkx2.2, and Sox10 serve as
modulators of later differentiation, for example by adjusting the
timing of oligodendrocyte differentiation (3). Quantitative RT-
PCR analysis revealed a significant reduction of these genes in
Prmt1flox/flox; Nes-Cre brain at birth. Moreover, the differences
becamemore evident at P10 when oligodendrocytematuration
is most active under normal conditions (Fig. 6C). Thus, the
down-regulation of these transcription factors may explain the
reason for suppressed differentiation of oligodendrocyte
and/or the reduced number of OLIG2	 cells. Taken together,
these data indicated that PRMT1 is a key regulator of oligoden-
drocyte differentiation during the CNS development.
Discussion
The aim of this study was to clarify the physiological role of
PRMT1 in the CNS. CNS-specific PRMT1 knock-out mice
exhibited morphological abnormalities of the brain, and many
of them died within 2 weeks after birth. Because they displayed
severe tremors, we analyzed CNS myelination and found that
they exhibit nearly complete loss of myelinating oligodendro-
cytes. In addition, oligodendrocyte lineages were significantly
decreased in CNS tissues. These results suggest that PRMT1
plays a crucial role in oligodendrocyte differentiation and CNS
development.
We showed that MBP	 mature oligodendrocytes were
almost lost in CNS-specific PRMT1 knock-out mice. Further-
more, we found only a small number of OLIG2	 oligodendro-
cyte lineages and OLIG2	MBP OPCs/immature oligoden-
drocytes in the mutant animals. At least two possibilities may
explain the decrease of these cells in CNS. First, it could be
caused by the decreased level of OPCs proliferation. OPCs
increase their number before differentiation into postmi-
totic oligodendrocytes (28). Thus, failure of this process will
directly affect the number of OLIG2	 oligodendrocyte line-
age cells. It is also likely that the increased cell death of OPCs
affected the lower cell number, for example by cell cycle
deregulation (5). By contrast, an alternative explanation is an
altered differentiation potential of NSCs. In other words,
PRMT1-deleted NSCs might have a low ability to differenti-
ate into OPCs. From these possible mechanisms, PRMT1
may modulate oligodendrocyte development not only at ter-
minal differentiation/myelination but also at the earlier
point of differentiation.
FIGURE 5. Severe hypomyelination and dramatic decrease ofmature oligodendrocytes in Prmt1flox/flox; Nes-Cremice. A, representative electronmicro-
graph images of corpus callosum (CC) and spinal cord (SC) of CTRL and CKO mice at P10. B, Western blot of MBP, CNPase, MAG, CRMP-2, III-tubulin, glial
fibrillary acidic protein (GFAP), and PRMT1 expression in the brain of CTRL and CKO mice at P10. C, immunostaining images of MBP (red) with nuclear
counterstain Hoechst (blue) in the cerebrum (Cr), cerebellum (Cb), and spinal cord (SC) of CTRL and CKOmice at P10. Thewhite boxed region from the Cr panels
ismagnified in theCC panels. Thewhite boxed region from the SC panels ismagnified and shown in the inset (right side). Scale bars represent 2m inA; 300m
in cerebrum, cerebellum, and spinal cord in C; and 100 m in magnified images of corpus callosum in C. Str, striatum.
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In the present study, we found that PRMT1 plays a critical
role in oligodendrocyte lineage progression. A previous study
has shown that PRMT5 knockdown in C6 rat glioma cells and
primary rat OPCs led to repressed maturation of oligodendro-
cyte, indicating that PRMT5 is important for oligodendrocyte
differentiation (12). These studies suggest that both PRMT1
and PRMT5 positively regulate oligodendrocyte development.
It is of note that PRMT1 and PRMT5 show distinct temporal
expression patterns in the brain (12). AlthoughPRMT1 shows a
strong expression at birth and then decreases as mice grow,
PRMT5 gradually increases after P11 and peaks at adult stage
(12). Given these distinct expression patterns, it is likely that
PRMT1 and PRMT5 control oligodendrocyte maturation in
different time points during CNS development.
Oligodendrocyte differentiation is tightly regulated by vari-
ous key transcription factors. Several studies have shown that
their interplay is important for proper oligodendrocyte devel-
opment (29–31). Id2 and Id4, which are known oligodendro-
cyte differentiation inhibitors, were up-regulated upon knock-
down of PRMT5 in rat primary OPCs and the C6 glioma cell
line (12). In C6 glioma cells, PRMT5 symmetrically dimethy-
lated arginine 3 of histone H4 (H4R3) to lead to repression of
these genes (12). In general, although symmetric dimethylation
of H4R3 (H4R3me2s) causes transcriptional repression (32),
asymmetric dimethylation of H4R3 (H4R3me2a) by PRMT1
induces gene transcriptional activation by permitting subse-
quent acetylation of chromatin, leading to the establishment of
an active state of chromatin (33, 34). In addition, a growing
amount of evidence suggests that PRMT1 positively regulates
gene expression by methylating transcriptional factors and
transcription coactivators (35–37). In light of these findings,
PRMT1 may regulate the function of key transcription factors
including Olig2, Sox10, or Nkx2.2. by methylation and modu-
late the timing of oligodendroglial maturation. Interestingly,
although these positive regulators of differentiation were
clearly decreased (Fig. 6C), differentiation inhibitors including
Id2 and Id4 were not changed in the brain of CNS-specific
PRMT1 knock-out mice at P0 and P10 (data not shown). This
observation also supports our novel hypothetical view that
PRMT1 and PRMT5 have different regulatory mechanisms of
oligodendrocyte differentiation.
CNS-specific PRMT1 knock-out neonates exhibited small
body size, and consequently, most of them died in 2 weeks. A
famous hypomyelinationmodel, shiverermouse (shi), has auto-
somal recessive mutation in Mbp gene. Shi mutant mice are
seemingly normal at birth but develop tremors later and die
within 5 months (18). When compared with shi, our model has
a shorter life span and is remarkably small and emaciated.
Because both models show nearly complete absence of myeli-
nation, the difference in life span and growth may not be
explained just by defective myelination. In many cases, gene
deletion of positive regulator of oligodendrocyte differentiation
factors results in perinatal death. For instance, Sox10-deficient
mice show defective oligodendrocyte development and die
either before birth or at birth (27, 38). Olig2 null mutant show
the complete absence of oligodendrocyte lineages and die at the
day of birth (24, 25). In the course of oligodendrocyte develop-
ment,Olig2 and Sox10 regulate initial and later differentiation,
and in comparison,Mbp is crucial for establishingmyelin struc-
ture. Considering that these proteins temporally regulate oligo-
dendrocyte development, PRMT1 may be important for cell
commitment to oligodendrocyte lineage before myelination. If
so, it is reasonable that our model dies earlier than the shi
mutant. Another possible reason for postnatal death in CNS-
specific PRMT1 knock-out animals may be attributed to fur-
ther deficiency in other cell lineages besides OPC/oligodendro-
FIGURE 6. Oligodendrocyte lineage cells were reduced in Prmt1flox/flox;
Nes-Cremice.A, immunostainingofOLIG2 (green) andMBP (red)withnuclear
counterstain Hoechst (blue) in the striatum of CTRL and CKOmice at P10. The
graph on the right shows the quantification of the number of OLIG2	MBP
cells in the striatum. Numbers represent the average of three sections per
each genotype from a single experiment. The data shown are mean  S.E.
and analyzed by a two-tailed Student’s t test. n 3 per each genotype. *, p

0.05 B, immunostaining of OLIG2 (green) with nuclear counterstain Hoechst
(blue) in the cerebellum (Cb) and the spinal cord (SC) of CTRL and CKOmice at
P10. C, relative gene expression ofOlig1,Olig2, Nkx2.2, and Sox10 in the brain
ofCTRLandCKOmiceat P0andP10asdeterminedbyquantitativeRT-PCR.All
data were normalized to Gapdh. All data shown are mean  S.E. and were
analyzed by a two-tailed Student’s t test. n 4 per each genotype.*, p
 0.05,
**, p
 0.01 Scale bars represent 100 m.
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cytes, althoughwe observed neuronal and astrocyticmarkers in
a similar level between the mutant and control mice.
In conclusion, this study provides evidence that PRMT1 is
critical for oligodendrocyte lineage progression. In addition,
decreased numbers of oligodendrocyte lineage cells suggest
that PRMT1 is a key regulator for the cell development of NSCs
and OPCs/immature oligodendrocytes in the CNS. Finally, the
present genetic model will enable future challenges on analyses
of additional functions of PRMT1 in the CNS.
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